Viewing Study NCT00081952



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00081952
Status: COMPLETED
Last Update Posted: 2013-03-22
First Post: 2004-04-27

Brief Title: Amino Acid Therapy for Hot Flashes in Postmenopausal Women
Sponsor: National Center for Complementary and Integrative Health NCCIH
Organization: National Center for Complementary and Integrative Health NCCIH

Study Overview

Official Title: Amino Acid Therapy for Hot FlashesPostmenopausal Women
Status: COMPLETED
Status Verified Date: 2013-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the safety tolerability and effectiveness of the amino acid L-isoleucine in the treatment of hot flashes in postmenopausal women
Detailed Description: Hot flashes affect approximately 75 of postmenopausal women Although hormone replacement therapy HRT is highly effective in reducing hot flashes long-term HRT is associated with increased rates of breast cancer and heart disease Safe effective and well-tolerated hot flash therapies are needed The amino acids L-methionine and L-isoleucine have produced reductions in hot flash frequency However long-term L-methionine therapy may increase cardiovascular risks This study will evaluate the short-term effects of L-isoleucine therapy Data from this study will be used to conduct long-term studies in the future

Participants in this study will be randomly assigned to receive one of two different L-isoleucine doses for 2 weeks Clinic visits will be made at baseline Week 1 and Week 10 Participants will record the frequency and severity of their hot flashes in a diary

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None